211 related articles for article (PubMed ID: 34958454)
1. Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis.
Fan WH; Wang FC; Jin Z; Zhu L; Zhang JX
Curr Med Sci; 2022 Feb; 42(1):108-117. PubMed ID: 34958454
[TBL] [Abstract][Full Text] [Related]
2. Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the miR-200a-3p-GLS axis.
Liu X; Chen L; Wang T
J Chemother; 2023 Jul; 35(4):357-366. PubMed ID: 36120905
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lncRNA NEAT1 sensitizes medulloblastoma cells to cisplatin through modulating the miR-23a-3p-glutaminase (GLS) axis.
Ge J; Wang B; Zhao S; Xu J
Bioengineered; 2022 Mar; 13(3):7670-7682. PubMed ID: 35313796
[TBL] [Abstract][Full Text] [Related]
4. miR-141-3p Promotes the Cisplatin Sensitivity of Osteosarcoma Cell through Targeting the Glutaminase [GLS]-Mediated Glutamine Metabolism.
Zhou X; Wei P; Wang X; Zhang J; Shi Y
Curr Mol Med; 2023; 23(2):177-184. PubMed ID: 34607540
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PVT1 Confers Cisplatin Resistance of Esophageal Cancer Cells through Modulating the miR-181a-5p-Glutaminase (GLS) Axis.
Chen Z; Wang Q; Huang L; Xu G; Hu J
Nutr Cancer; 2023; 75(8):1646-1657. PubMed ID: 37401860
[TBL] [Abstract][Full Text] [Related]
6. LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells.
Zheng ZH; You HY; Feng YJ; Zhang ZT
Mol Cell Biochem; 2021 Jul; 476(7):2575-2585. PubMed ID: 32757174
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism.
Chang X; Zhu W; Zhang H; Lian S
Clin Exp Dermatol; 2017 Aug; 42(6):614-621. PubMed ID: 28597996
[TBL] [Abstract][Full Text] [Related]
8. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
9. Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.
Chen P; Liu XQ; Lin X; Gao LY; Zhang S; Huang X
Mol Ther Oncolytics; 2021 Mar; 20():228-239. PubMed ID: 33614908
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
Cui Z; Wang Q; Deng MH; Han QL
Cancer Biomark; 2022; 34(1):41-53. PubMed ID: 34542064
[TBL] [Abstract][Full Text] [Related]
11. SNHG14 stimulates cell autophagy to facilitate cisplatin resistance of colorectal cancer by regulating miR-186/ATG14 axis.
Han Y; Zhou S; Wang X; Mao E; Huang L
Biomed Pharmacother; 2020 Jan; 121():109580. PubMed ID: 31704614
[TBL] [Abstract][Full Text] [Related]
12. LncRNA XIST Contributes to Cisplatin Resistance of Lung Cancer Cells by Promoting Cellular Glycolysis through Sponging miR-101-3p.
Hua G; Zeng ZL; Shi YT; Chen W; He LF; Zhao GF
Pharmacology; 2021; 106(9-10):498-508. PubMed ID: 34352791
[TBL] [Abstract][Full Text] [Related]
13. Circ-CREBBP promotes cell tumorigenesis and glutamine catabolism in glioma by regulating miR-375/glutaminase axis.
Zhang L; Ye L; Xu Z; Jin Y; Song D
Brain Res; 2022 Jan; 1775():147730. PubMed ID: 34813772
[TBL] [Abstract][Full Text] [Related]
14. Targeting PTBP1 blocks glutamine metabolism to improve the cisplatin sensitivity of hepatocarcinoma cells through modulating the mRNA stability of glutaminase.
Tian R; Li Y; Shen X; Li Y
Open Med (Wars); 2023; 18(1):20230756. PubMed ID: 37724122
[TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer.
Zhang J; Liu J; Xu X; Li L
Cancer Chemother Pharmacol; 2017 Mar; 79(3):479-487. PubMed ID: 28175963
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-200c exacerbates the ischemia/reperfusion injury of heart through targeting the glutaminase (GLS)-mediated glutamine metabolism.
Liu F; Li Y; Liu G
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3282-3289. PubMed ID: 28770953
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53.
Xu R; Li H; Wu S; Qu J; Yuan H; Zhou Y; Lu Q
Int Urol Nephrol; 2019 Oct; 51(10):1771-1779. PubMed ID: 31236854
[TBL] [Abstract][Full Text] [Related]
18. Curcumin, calebin A and chemosensitization: How are they linked to colorectal cancer?
Brockmueller A; Samuel SM; Mazurakova A; Büsselberg D; Kubatka P; Shakibaei M
Life Sci; 2023 Apr; 318():121504. PubMed ID: 36813082
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
20. microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 2.
Chen W; Chen Y; Hui T
J Chemother; 2023 Oct; 35(6):539-549. PubMed ID: 36546770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
